π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
A prospective, multi-centre, diagnostic cohort study investigating the accu...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2019-08-08
Trial ID
NCT03937362
Treatments Being Tested
This study aims to evaluate the efficacy and safety of adebrelimab consolid...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-07-17
Trial ID
NCT07559786
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00417053
Treatments Being Tested
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
1994-09
Trial ID
NCT00002596
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2021-12-01
Trial ID
NCT04747054
Treatments Being Tested
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This randomized phase III trial is studying carboplatin, paclitaxel, radiat...
Status
Terminated
Location
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Start Date
2000-01
Trial ID
NCT00004859
Treatments Being Tested
The aim of this research study is to evaluate the effectiveness and safety ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2025-06-17
Trial ID
NCT06940180
Treatments Being Tested
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945